Latest Content

In an exploration of the National Retail Data Monitor, researchers determine how OTC sales contributed to disease surveillance.

Person-centric packaging enhances medication adherence for type 2 diabetes patients, simplifying therapy and improving outcomes, according to recent studies.

John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.

John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.

Dietary nutrients show promise in reducing asthma risk linked to indoor air pollution, offering new strategies for pharmacists in patient care.

The agency’s findings spur promises of significant change to the development and recommendations surrounding various immunizations.

Researchers investigate serotype distribution and antimicrobial resistance among children in Mexico with pneumococcal meningitis.

Morgan McSweeney, PhD, discusses America's public health decision-making, urging reforms to combat misinformation and safeguard scientific integrity in health agencies.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

Researchers conduct a cost-effectiveness analysis to uncover the public health and economic impacts of PCV20 among Australian children.

Community pharmacies are facing major barriers due to PBM practices and vertical integration, ultimately jeopardizing patient access and trust in health care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Wesley Sparkmon, PhD, MPH, assistant professor of pharmacy sciences at Creighton University.

Novo Nordisk announced results of the evoke and evoke+ phase 3 trials on semaglutide’s use in treating Alzheimer disease progression.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Morgan McSweeney, PhD, discusses how social media highlights the most emotionally charged voices, often those offering anecdotes or outrage over careful analysis.

Tardive dyskinesia presents significant challenges for patients, but new FDA-approved treatments offer hope for improved management and quality of life.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.

Catie Stimmel, PharmD, discusses what PSOs are and how they are protecting patients all across the US health care system.

High-profile figures often share misleading health information, highlighting the need for trusted and evidence-based content in social media discussions.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

Conflicting health guidance from authorities creates confusion and erodes public trust, impacting access to medical care and long-term health outcomes.

After nearly 20 years of pneumococcal conjugate vaccine use in the Portuguese vaccine schedule, researchers explore serotype distribution in bacteria causing adult invasive pneumococcal disease (IPD).

The CDC states that the claim “vaccines do not cause autism” is not evidence based because studies have not ruled out the possibility that infant vaccines cause autism.

A conversation with NCPDP’s Rick Sage explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.

Regeneron Pharmaceuticals’ newest drug will be the first and only approved flexible treatment option for retinal vein occlusion.

The FDA approves denosumab biosimilars Osvyrti and Jubereq, expanding treatment options for osteoporosis and bone-related conditions.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Patients tend to trust their physician to deprescribe more than their community pharmacist.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with pharmacists from Ohio State University to discuss smoking trends among women.